Boston, Massachusetts 2021-09-20 13:31:25 –
MeIn a rare step, the European Commission plans to intervene in the recent merger between Illumina (ILMN) And Grail raise concerns that regulatorys could not complete a transaction review before the transaction was completed, which could undermine competition in the DNA sequencing test market.
The move happens a month after Illumina surprises regulators. Presentation Completed $ 8 Billion Acquisition Despite EC Having open A survey prompted by France and five other European Union member states just a few weeks ago.In the United States, the Federal Trade Commission is already Complaints March last year to block transactions.
European Commission seeks to intervene in Illumina’s acquisition of Grail Source link European Commission seeks to intervene in Illumina’s acquisition of Grail